July 23, 2026 —The American Society of Echocardiography (ASE) and the ASE Foundation (ASEF) have named Nicholas Spetko ...
July 22, 2026 — Penumbra, Inc. recently announced the results of Thunder, an Investigational Device Exemption (IDE) ...
July 23, 2026 — HOPPR has introduced HOPPR EF Chest CT Narrative Model, a foundation model that processes 3D chest CT ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
July 21, 2026 — ElectroWire Medical recently announced that the U.S. Food and Drug Administration (FDA) has granted 510 ...
July 21, 2026 — Women who experience pregnancy complications face an increased risk of developing peripheral artery ...
July 22, 2026 — Ultromics has announced results from an independent clinical data set that shows the company’s EchoGo ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
July 20, 2026 — Young women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovarian ...
July 21, 2026 — Vesalio recently announced that the results from the randomized NATURE clinical trial evaluating the ...
July 16, 2025 — Insmed Inc. recently announced positive 12-Month data from the ongoing open-label extension (OLE) study ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
July 16, 2026 — Imperative Care has introduced the Ikon 24 Pro Guidewire, a neurovascular guidewire purpose-built to ...
July 16, 2026 — Merck has received U.S. Food and Drug Administration (FDA) approval for Lipfendra (enlicitide) tablets ...
July 8, 2026 — Conavi Medical Corp. has announced the publication of a case report in the Journal of the Society for ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
July 13, 2026 — UltraSight has announced new clinical data from a prospective, peer-reviewed clinical study evaluating ...
July 14, 2026 — Atrium Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has cleared its ...
July 9, 2026 — AccurKardia, Inc. and Wellysis have announced a multi-year agreement under which AccurKardia’s AccurECG 2 ...
July 27, 2026
